Application of Al-Wujūh Wa Naẓāʾir in Tafsir Al-Baḥr Ul-Muḥīṭ by Abu Hayyan Al-Andalusi
Al-Asr International Research Journal of Islamic Studies · 29.06.2025 · 5 (2) · 1250-1263
DOI: 10.68696/alasr.356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Asr International Research Journal of Islamic Studies, online erschienen am 29.06.2025. Verfasst von Professor Dr Shfaqat Ali Al Azhari und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This study investigates the Observation and application of Wujūh wa Naẓāʾir (Qur’anic polysemy) in Abu Hayyan al-Andalusi’s exegesis, Al-Baḥr al-Muḥīṭ. It explores how Abu Hayyan utilized his expertise in linguistics, grammar, and rhetoric to navigate semantic variations and contextual indicators within the Qur’anic text. By analyzing his methodological treatment of lexical multiplicity and comparing it with earlier works, the research demonstrates how he integrated this science into his exegetical practice—even where not explicitly categorized as such. The findings reveal that Abu Hayyan’s approach relies heavily on syntactic context and linguistic precision, significantly contributing to the development of Qur’anic semantic studies.
Zitieren
APA
Azhari, P. D. S. A. A., & Nadeem, P. D. A. M. (2025). Application of Al-Wujūh Wa Naẓāʾir in Tafsir Al-Baḥr Ul-Muḥīṭ by Abu Hayyan Al-Andalusi. Al-Asr International Research Journal of Islamic Studies, 5(2), 1250-1263. https://doi.org/10.68696/alasr.356
Vancouver
Azhari PDSAA, Nadeem PDAM. Application of Al-Wujūh Wa Naẓāʾir in Tafsir Al-Baḥr Ul-Muḥīṭ by Abu Hayyan Al-Andalusi. Al-Asr International Research Journal of Islamic Studies. 2025;5(2):1250-1263. doi:10.68696/alasr.356
BibTeX
@article{Azhari2025,
author = {Azhari, Professor Dr Shfaqat Ali Al and Nadeem, Professor Dr Abdul Majid},
title = {Application of Al-Wujūh Wa Naẓāʾir in Tafsir Al-Baḥr Ul-Muḥīṭ by Abu Hayyan Al-Andalusi},
journal = {Al-Asr International Research Journal of Islamic Studies},
year = {2025},
volume = {5},
number = {2},
pages = {1250--1263},
doi = {10.68696/alasr.356}
}
EUVIMED